Form 8-K GALECTIN THERAPEUTICS For: Aug 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Galectin (GALT) Posts Q2 Loss of 17c/Share
August 7, 2014 5:26 PM EDTGalectin (NASDAQ: GALT) reported Q2 EPS of ($0.17), $0.04 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Galectin (GALT) click here.
... More


